Blood samples were taken at various time-points (0, 8, 20, 41, and 58 days) after tumor cell injection and the frequency of OVA-specific CD8+ T cells was plotted for mice receiving three (Figure 5A) or two (Figure 5B) vaccinations. This evidence concerns the gene CD8A and neoplasm.